Growth Metrics

Rigel Pharmaceuticals (RIGL) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.15%
Dec 31, 2025 232.87%
Sep 30, 2025 43.54%
Jun 30, 2025 341.29%
Mar 31, 2025 464.69%
Dec 31, 2024 122.47%
Sep 30, 2024 51.07%
Jun 30, 2024 5.55%
Mar 31, 2024 -10.57%
Dec 31, 2023 10.02%
Sep 30, 2023 -13.23%
Jun 30, 2023 -15.90%
Mar 31, 2023 -78.15%
Dec 31, 2022 31.35%
Sep 30, 2022 -439.41%
Jun 30, 2022 -154.09%
Mar 31, 2022 -77.62%
Dec 31, 2021 -38.85%
Sep 30, 2021 -27.07%
Jun 30, 2021 -13.01%
Mar 31, 2021 130.11%
Dec 31, 2020 -33.22%
Sep 30, 2020 -19.39%
Jun 30, 2020 -19.48%
Mar 31, 2020 45.87%
Dec 31, 2019 -21.91%
Sep 30, 2019 -11.98%
Jun 30, 2019 -17.86%
Mar 31, 2019 -13.25%
Dec 31, 2018 6.19%
Sep 30, 2018 -16.26%
Jun 30, 2018 54.83%
Mar 31, 2018 -20.71%
Dec 31, 2017 79.19%
Sep 30, 2017 -19.31%
Jun 30, 2017 -17.22%
Mar 31, 2017 52.80%
Dec 31, 2016 -16.55%
Sep 30, 2016 -10.55%
Jun 30, 2016 -2.30%
Mar 31, 2016 -17.43%
Dec 31, 2015 -5.21%
Sep 30, 2015 -4.69%
Jun 30, 2015 -9.81%
Mar 31, 2015 -12.55%
Dec 31, 2014 -12.67%
Sep 30, 2014 -11.39%
Jun 30, 2014 -12.00%
Mar 31, 2014 -9.57%
Dec 31, 2013 -6.78%
Sep 30, 2013 -8.83%
Jun 30, 2013 -7.64%
Mar 31, 2013 -8.23%
Dec 31, 2012 65.38%
Sep 30, 2012 -10.70%
Jun 30, 2012 -9.62%
Mar 31, 2012 -8.29%
Dec 31, 2011 -8.46%
Sep 30, 2011 -5.40%